| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.0086 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0086 | 1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |